PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin
Status:
Completed
Trial end date:
2013-07-01
Target enrollment:
Participant gender:
Summary
This clinical research study is to investigate the prevention of relapse in patients with
diffuse large B cell lymphoma (DLBCL) using enzastaurin daily.
This is a randomised trial which compares Enzastaurin to Placebo (dummy treatment), the
chance of receiving Enzastaurin is 2 to 1.